Trained human bone marrow mesenchymal stem cells restore tissue immuno-microenvironment in fulminant hepatic failure mice

by admin | Aug 21, 2025 | News & Opinions

By BMC – Part of SpringerNature – Trained immunity with human bone marrow mesenchymal stem cells (hBMSC) is a promising approach to liver regeneration. This study aimed to clarify the trained-hBMSC (T-hBMSC) in restoring tissue immuno-microenvironment in...

ARPA-H data chief departs over disagreement with mRNA vaccine rollback

by admin | Aug 20, 2025 | News & Opinions

By Darren Incorvaia – Fierce Biotech – After the Department of Health and Human Services canceled about $500 million in funding for mRNA vaccine development, one senior agency leader has decided to call it quits. Alastair Thomson is resigning as chief data...

VA’s first bloodless stem cell transplant leads to Veteran’s cancer remission

by admin | Aug 19, 2025 | News & Opinions

By Abby Woodruff – Veterans Affairs – Earlier this year, VA Tennessee Valley Healthcare System (TVHS) performed the first-ever bloodless autologous stem cell transplant in the VA system. Keith Cody, a Marine Corps Veteran, walked out of TVHS in remission...

Study using stem cells created from ALS patients identifies potential new target for treatment

by admin | Aug 18, 2025 | News & Opinions

by Case Western Reserve University – The Daily – CLEVELAND—Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control voluntary...

Uncertainty clouds the San Diego biotech hub, with jobs and capital scarce

by admin | Aug 15, 2025 | News & Opinions

By Jonathan Wosen – Stat – But optimism pokes through, as VC returns and local biotech stocks have fared well Ever since Vince Kato was laid off, he has felt like he was just two to three months away from landing a new position. But more than a year later,...